CK Life Sciences International (Holdings) Inc. held its Annual General Meeting on 22nd May, 2025. During the meeting, several proposals were put forward and approved, including the receipt of audited financial statements and reports for the year ended 31st December, 2024, the election of Victor T K Li, Kam Hing Lam, and Yu Ying Choi, Alan Abel as directors, and granting a general mandate to the directors to buy back shares of the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.